![]() |
市場調查報告書
商品編碼
1902576
感染監測解決方案市場規模、佔有率和成長分析(按產品/服務、最終用戶和地區分類)—產業預測(2026-2033 年)Infection Surveillance Solutions Market Size, Share, and Growth Analysis, By Product & Service (Software, Services), By End User (Hospitals, Long-Term Care Facilities), By Region-Industry Forecast 2026-2033 |
||||||
預計到 2024 年,感染監測解決方案市場規模將達到 7.3324 億美元,到 2025 年將成長至 8.3516 億美元,到 2033 年將成長至 23.6571 億美元,在預測期(2026-2033 年將成長到 23.6571 億美元,在預測期(2026-2033 年成長率)內年成長率為 13.複合年成長率。
由於院內感染 (HAI) 的發生率不斷上升以及微生物對抗生素的抗藥性日益增強,感染監測解決方案市場正經歷顯著成長。自動化在醫療保健領域日益廣泛的應用也進一步推動了這個市場的發展。全球外科手術數量的激增導致住院時間延長,並增加了患者院內感染的發生率。這一趨勢正積極影響醫療機構對感染監測解決方案的需求,這些解決方案用於監測和分析感染的發生率、傳播和影響。利用先進的數據收集、整合和分析工具,這些解決方案能夠有效追蹤各種醫療相關感染,包括血流感染、手術部位感染和呼吸道感染疾病。它們有助於早期發現疫情並提高病患安全,從而推動了全球對感染監測解決方案的需求。
全球感染監測解決方案市場按產品/服務、最終用戶和地區進行細分。依產品/服務分類,市場分為軟體和服務兩大類。依最終用戶分類,市場分為醫院、長期照護機構和其他最終用戶。依地區分類,市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。
感染監測解決方案市場促進因素
在全球範圍內,糖尿病、心血管疾病和代謝性疾病等慢性病的日益增多導致住院人數增加,患者住院時間延長。這一趨勢增加了患者的感染風險,因此亟需部署完善的感染監測解決方案。這些系統對於有效管理感染風險、確保更好的健康結果以及最終提高患者的生活品質至關重要。透過主動監測和應對潛在感染,醫療機構可以提高病患安全並簡化治療流程。這無疑推動了醫療機構對先進感染監測技術的需求。
感染監測解決方案市場限制因素
感染監測解決方案市場面臨許多限制因素,主要原因是醫護人員、病患和看護者普遍缺乏對醫院感染的認知。有效的溝通和教育工作對於提高人們對這些感染疾病的了解以及對感染監測系統益處的認知至關重要。在開發中國家,人們往往對這些系統所知甚少,加之資金匱乏和基礎建設不足,會嚴重阻礙市場成長。總而言之,這些障礙影響著感染監測解決方案在這些地區的普及和廣泛應用。
感染監測解決方案市場趨勢
隨著醫療相關感染 (HAI) 的增加,對有效監測系統的需求日益迫切,感染監測解決方案市場正經歷顯著成長。醫療機構將病患安全和醫療品質放在首位,因此對能夠追蹤、管理和控制感染爆發的強大監測技術的需求激增。感染疾病的增加進一步凸顯了全面感染控制策略的重要性,為該領域的創新創造了巨大機會。因此,醫療服務提供者正在加大對先進監測解決方案的投資,預計未來幾年該市場將取得顯著進步並廣泛應用。
Infection Surveillance Solutions Market size was valued at USD 733.24 Million in 2024 and is poised to grow from USD 835.16 Million in 2025 to USD 2365.71 Million by 2033, growing at a CAGR of 13.9% during the forecast period (2026-2033).
The infection surveillance solutions market is witnessing significant growth driven by the rising incidence of hospital-acquired infections (HAIs) and increasing microbial resistance to antibiotics. Automation's expanding role in healthcare settings further propels market expansion. The surge in global surgeries has led to longer hospital stays, thereby escalating the number of HAIs among patients. This trend positively impacts demand for infection surveillance solutions, which healthcare facilities employ to monitor and analyze infection prevalence, spread, and effects. Utilizing advanced data gathering, integration, and analysis tools, these solutions effectively track various healthcare-associated infections, such as bloodstream, surgical site, and respiratory infections. Their capability to facilitate early outbreak detection and enhance patient safety is driving global demand for infection surveillance solutions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Infection Surveillance Solutions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Infection Surveillance Solutions Market Segments Analysis
Global Infection Surveillance Solutions Market is segmented into Product & Service, End User, and region. By Product & Service, the market is classified into Software, and Services. Depending on the End User, it is categorized into Hospitals, Long-Term Care Facilities, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Infection Surveillance Solutions Market
The global rise in chronic conditions such as diabetes, cardiovascular diseases, and metabolic disorders is leading to increased hospitalizations and extended patient stays. This trend heightens the vulnerability of patients to infections, necessitating the implementation of robust infection surveillance solutions. These systems are essential for effectively managing infection risks, ensuring better health outcomes, and ultimately enhancing patients' quality of life. By actively monitoring and addressing potential infections, healthcare providers can improve patient safety and streamline the treatment process, underscoring the increasing demand for advanced infection surveillance technologies in medical settings.
Restraints in the Infection Surveillance Solutions Market
The Infection Surveillance Solutions market faces significant restraints primarily due to a general lack of awareness among medical professionals, patients, and caregivers regarding hospital infections. Effective communication and educational initiatives are crucial for enhancing understanding of these infections and the advantages of infection surveillance systems. In developing economies, there is often a notable deficiency in knowledge about these systems, compounded by insufficient financial resources and inadequate infrastructure, which can severely impede market growth. These barriers collectively impact the ability of infection surveillance solutions to gain traction and achieve widespread adoption in those regions.
Market Trends of the Infection Surveillance Solutions Market
The Infection Surveillance Solutions market is experiencing significant growth driven by the rising prevalence of Healthcare-Associated Infections (HAIs), which has heightened the urgency for effective monitoring systems. As healthcare facilities prioritize patient safety and quality of care, the demand for robust surveillance technologies capable of tracking, managing, and controlling infection outbreaks has surged. The escalation of infectious diseases further amplifies the need for comprehensive infection control strategies, creating vast opportunities for innovation in this sector. Consequently, healthcare providers are increasingly investing in advanced surveillance solutions, positioning the market for substantial advancements and adoption in the coming years.